Friday, 21 September 2018

New Possibilities of Diagnostics of Non-Alcoholic Fatty Liver Disease: (CTGH)-Lupine Publishers


New Possibilities of Diagnostics of Non-Alcoholic Fatty Liver Disease by Pirogova I Yu in Current Trends in Gastroenterology and Hepatology in Lupine Publishers


The aim of the study was to create a non-invasive model for diagnosing fibrosis and steatosis in non-alcoholic fatty liver disease. Materials and methods. The study included 183 patients with liver steatosis according to ultrasound of the liver. General clinical examination, verification of the stage of fibrosis and steatosis of the liver on the Fibroscan 502 TOUCH device with the CAP software was carried out. Results of the study. Fibrosteatotest ©, based on stigmas of inflammation activity, insulin resistance, lipid spectrum for the diagnosis of fibrosis and steatosis (diagnostic accuracy of more than 80% compared to the results of fibroscanning), is created by the method of discriminant analysis, which allows to identify patients with the 2nd and more stage of fibrosis and steatosis of the liver, who need medication.

No comments:

Post a Comment

Note: only a member of this blog may post a comment.